Copyright Reports & Markets. All rights reserved.

Global In-Vitro Toxicology and Toxicity Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis
    • 1.3.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate : 2020 VS 2026
    • 1.3.2 Cell Culture Technology
    • 1.3.3 High Throughput Technologies
    • 1.3.4 Molecular Imaging Technologies
    • 1.3.5 Omics Technologies
  • 1.4 Market by Application
    • 1.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Share : 2020 VS 2026
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Chemical Industry
    • 1.4.4 Food Industry
    • 1.4.5 Other
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2015-2026)
  • 2.2 In-Vitro Toxicology and Toxicity Testing Growth Trends by Regions
    • 2.2.1 In-Vitro Toxicology and Toxicity Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 In-Vitro Toxicology and Toxicity Testing Industry Dynamic
    • 2.3.1 In-Vitro Toxicology and Toxicity Testing Market Trends
    • 2.3.2 In-Vitro Toxicology and Toxicity Testing Market Drivers
    • 2.3.3 In-Vitro Toxicology and Toxicity Testing Market Challenges
    • 2.3.4 In-Vitro Toxicology and Toxicity Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Market Size
    • 3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2015-2020)
    • 3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
  • 3.4 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
    • 3.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2019
  • 3.5 Key Players In-Vitro Toxicology and Toxicity Testing Area Served
  • 3.6 Key Players In-Vitro Toxicology and Toxicity Testing Product Solution and Service
  • 3.7 Date of Enter into In-Vitro Toxicology and Toxicity Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 In-Vitro Toxicology and Toxicity Testing Breakdown Data

  • 4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size (2015-2020)
  • 4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size (2021-2026)

5 In-Vitro Toxicology and Toxicity Testing Breakdown Data

  • 5.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size (2015-2020)
  • 5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size (2021-2026)

6 North America

  • 6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
  • 6.2 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
  • 7.2 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
  • 8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 8.4 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
  • 9.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 9.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2015-2020)
  • 9.4 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size (2015-2026)
  • 10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11 Key Players Profiles

  • 11.1 GE Healthcare
    • 11.1.1 GE Healthcare Company Details
    • 11.1.2 GE Healthcare Business Overview
    • 11.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020))
    • 11.1.5 GE Healthcare Recent Development
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Company Details
    • 11.2.2 Thermo Fisher Scientific Business Overview
    • 11.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.2.5 Thermo Fisher Scientific Recent Development
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Business Overview
    • 11.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.3.5 Bio-Rad Laboratories Recent Development
  • 11.4 Agilent Technologies
    • 11.4.1 Agilent Technologies Company Details
    • 11.4.2 Agilent Technologies Business Overview
    • 11.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.4.5 Agilent Technologies Recent Development
  • 11.5 Cyprotex
    • 11.5.1 Cyprotex Company Details
    • 11.5.2 Cyprotex Business Overview
    • 11.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.5.5 Cyprotex Recent Development
  • 11.6 Covance
    • 11.6.1 Covance Company Details
    • 11.6.2 Covance Business Overview
    • 11.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.6.5 Covance Recent Development
  • 11.7 Bioreliance
    • 11.7.1 Bioreliance Company Details
    • 11.7.2 Bioreliance Business Overview
    • 11.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.7.5 Bioreliance Recent Development
  • 11.8 Catalent
    • 11.8.1 Catalent Company Details
    • 11.8.2 Catalent Business Overview
    • 11.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.8.5 Catalent Recent Development
  • 11.9 Charles River Laboratories International
    • 11.9.1 Charles River Laboratories International Company Details
    • 11.9.2 Charles River Laboratories International Business Overview
    • 11.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.9.5 Charles River Laboratories International Recent Development
  • 11.10 Alere
    • 11.10.1 Alere Company Details
    • 11.10.2 Alere Business Overview
    • 11.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
    • 11.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 11.10.5 Alere Recent Development
  • 11.11 Eurofins Scientific
    • 10.11.1 Eurofins Scientific Company Details
    • 10.11.2 Eurofins Scientific Business Overview
    • 10.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
    • 10.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 10.11.5 Eurofins Scientific Recent Development
  • 11.12 Life Technologies Corporation
    • 10.12.1 Life Technologies Corporation Company Details
    • 10.12.2 Life Technologies Corporation Business Overview
    • 10.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
    • 10.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 10.12.5 Life Technologies Corporation Recent Development
  • 11.13 Quest Diagnostics
    • 10.13.1 Quest Diagnostics Company Details
    • 10.13.2 Quest Diagnostics Business Overview
    • 10.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
    • 10.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2015-2020)
    • 10.13.5 Quest Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    In-Vitro Toxicology and Toxicity Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-Vitro Toxicology and Toxicity Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast and in terms of revenue and forecast for the period 2015-2026.

    Market segment , the product can be split into
    Cell Culture Technology
    High Throughput Technologies
    Molecular Imaging Technologies
    Omics Technologies

    Market segment , split into
    Pharmaceutical Industry
    Chemical Industry
    Food Industry
    Other

    Based on regional and country-level analysis, the In-Vitro Toxicology and Toxicity Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global In-Vitro Toxicology and Toxicity Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    GE Healthcare
    Thermo Fisher Scientific
    Bio-Rad Laboratories
    Agilent Technologies
    Cyprotex
    Covance
    Bioreliance
    Catalent
    Charles River Laboratories International
    Alere
    Eurofins Scientific
    Life Technologies Corporation

    Buy now